Morphine and enkephalin effects on hypothalamic glucoresponsive neurons

Chemoenzymatic synthesis and antitumor promoting activity of 6'- and 3-esters of 2-O-beta-D-glucosylglycerol.

Bioorganic & medicinal chemistry·1999

Inhibitory effects of monoacylated 2-O-beta-galactosylglycerols on Epstein-Barr virus activation: the significant role of the hexanoyl chain.

Cancer letters·1999

Anti-tumor promoting activity of polyphenols from Cowania mexicana and Coleogyne ramosissima.

Cancer letters·1999

Cancer chemopreventive agents (antitumor-promoters) from Ajuga decumbens.

Journal of natural products·1999

Anti-tumor-promoting effects of phenylpropanoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis.

Cancer letters·1999

The relationship between levels of neutrophil-related factors and the degree of surgical stress.

International surgery·1999

Dissociable neural mechanisms of cognitive enhancement through transcranial stimulation and behavioral training.

Brain research·2026

Perineuronal nets preferentially surround parvalbumin interneurons in the prelimbic cortex: A rat and mouse comparison.

Brain research·2026

System-level disruption of cortical temporal integration after stroke: linking intrinsic neural timescales to molecular and neurochemical architecture.

Brain research·2026

Nimodipine in animal models of demyelination relevant to multiple sclerosis: a systematic review.

Brain research·2026

Reconstructing regenerative niches in the central nervous system: Molecular and microenvironmental determinants of axonal regeneration.

Brain research·2026

Transferrin receptor upregulation mediates homocysteine-induced cytotoxicity in cerebral endothelial cells.

Brain research·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

Morphine and enkephalin effects on hypothalamic glucoresponsive neurons

Related Concept Videos

Chemoenzymatic synthesis and antitumor promoting activity of 6'- and 3-esters of 2-O-beta-D-glucosylglycerol.

Inhibitory effects of monoacylated 2-O-beta-galactosylglycerols on Epstein-Barr virus activation: the significant role of the hexanoyl chain.

Anti-tumor promoting activity of polyphenols from Cowania mexicana and Coleogyne ramosissima.

Cancer chemopreventive agents (antitumor-promoters) from Ajuga decumbens.

Anti-tumor-promoting effects of phenylpropanoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis.

The relationship between levels of neutrophil-related factors and the degree of surgical stress.

Dissociable neural mechanisms of cognitive enhancement through transcranial stimulation and behavioral training.

Perineuronal nets preferentially surround parvalbumin interneurons in the prelimbic cortex: A rat and mouse comparison.

System-level disruption of cortical temporal integration after stroke: linking intrinsic neural timescales to molecular and neurochemical architecture.

Nimodipine in animal models of demyelination relevant to multiple sclerosis: a systematic review.

Reconstructing regenerative niches in the central nervous system: Molecular and microenvironmental determinants of axonal regeneration.

Transferrin receptor upregulation mediates homocysteine-induced cytotoxicity in cerebral endothelial cells.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

Morphine and enkephalin effects on hypothalamic glucoresponsive neurons

Related Concept Videos

Related Articles